Therapeutic Advances in Hematology
该刊是一份经过同行评审的开放获取期刊，提供高质量原创研究、综述等，内容涉及血液学相关领域的开拓性工作和创新性研究。
影响因子：3.4，JCR Q2，HEMATOLOGY 28/97
Elisabetta Abruzzese, MD, PhD
Tor Vergata University
Dr. Elisabetta Abruzzese is a highly qualified medical professional with an MD and PhD in Haematology, as well as a fellowship in Cancer Biology. She currently works as an MD at S. Eugenio Hospital, ASL Roma2, Tor Vergata University, Rome, Italy. Dr. Abruzzese serves as the Head of the Clinical Research Group on Chronic Myeloid Leukaemia (CML) and Myelo Proliferative Neoplasm (MPN) and also coordinates the lymphoma clinic at the same hospital.
Cedric Hermans, MD, PhD, FRCP
St-Luc University Hospital
Cedric Hermans is the current head of the Division of Haematology, Hemostasis and Thrombosis Unit, as well as the Hemophilia Center at Saint-Luc University Hospital in Brussels, Belgium. He was appointed Associate Professor at the Medical School of the Catholic University of Louvain in 2003, Full Professor in 2012, and Vice-Dean in 2015.
Elias Jabbour, MD
M.D. Anderson Cancer Center
Elias Jabbour, MD, is a professor of medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center (MDACC) in Houston, Texas. He obtained his medical degree from Saint Joseph University School of Medicine in Beirut, followed by a residency at Hotel Dieu de France University Hospital. Dr. Jabbour then completed a fellowship in hematology-oncology at the Gustave Roussy Institute in France before joining MDACC as a fellow in the Department of Hematology/Leukemia and Stem Cell Transplantation in 2003. He later became an assistant professor in the Leukemia Department.
Wojciech Jurczak, MD, PhD
Maria Sklodowska-Curie National Research Institute of Oncology
Wojciech Jurczak is a consultant and professor of hematology at Maria Sklodowska Curie National Research Institute of Oncology, in Cracow, Poland, where he leads the Lymphoid Malignancy Department. He has been involved in research activities related to the development of monoclonal antibodies in B cell lymphomas, including Y90 labeled Ibritumomab tiuxetan and practical aspects of stem cell transplantation.
Michaela Liedtke, MD
Stanford Cancer Institute
Michaela Liedtke, MD is Associate Professor of Medicine at the Stanford University School of Medicine. She holds several positions at Stanford Cancer Institute, including Medical Director of the Hematology Inpatient Service, Co-Director of the Stanford Adolescent and Young Adult Cancer Program, and Co-Director of the Stanford Amyloid Center.
Sarah K. Tasian, MD
University of Pennsylvania School of Medicine
Sarah K Tasian, MD is a pediatric oncologist and physician-scientist at the Children’s Hospital of Philadelphia (CHOP) and an Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine who is interested in development of molecularly-targeted therapeutics for children with high-risk leukemias.
王建祥 教授
中国医学科学院北京协和医学院
Dr. Raymond Siu-Ming WONG
香港中文大学医学院
如果您对以上期刊感兴趣，想要投稿，Sage提供预审稿服务，欢迎扫码申请！
扫描上方二维码，关注“Sage学术”官方微信，然后在弹出的链接中填写相关信息，留下联系方式，即有专人与您联系。
END
Sage
扫码关注我们
微信号｜Sage世哲
新浪微博｜Sage世哲
世界领先的独立学术出版商，由Sara Miller McCune女士创立于1965年，以支持有价值的知识传播和全球教育为宗旨。Sage与全球超过400家专业学术协会合作出版1100余本高品质学术期刊。
